SCHEMBL4257835

SCHEMBL4257835

CCC(C)(C)NC(=N)N(C#N)c1cccnc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.40
CYP3A4 P08684 2/20 0.40
MEN1 O00255 1/20 0.40
ABCC9 O60706 1/20 0.40
CYP2D6 P10635 1/20 0.40
KMT2A Q03164 1/20 0.40
ABCC8 Q09428 1/20 0.40
KCNJ11 Q14654 1/20 0.40
KCNJ8 Q15842 1/20 0.40
MAPK1 P28482 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.34
ALDH1A1 P00352 1/20 0.34
RIPK1 Q13546 1/20 0.34
KDM4E B2RXH2 1/20 0.33
HTT P42858 1/20 0.33
LMNA P02545 1/20 0.32
NPSR1 Q6W5P4 2/20 0.32
GAA P10253 1/20 0.32
FKBP1A P62942 1/20 0.32
KCNN4 O15554 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9844273 0.84 NPSR1 (0.35) CYP3A4MEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL9815098 0.78 LMNA (0.32) CYP1A2CYP3A4MEN1ABCC9CYP2D6
SCHEMBL18093388 0.72 ABCC9 (0.46) CYP1A2CYP3A4MEN1ABCC9CYP2D6
SCHEMBL19371437 0.72 POLB (0.44) CYP1A2CYP3A4KMT2AMAPK1ALDH1A1
SCHEMBL7024139 0.68 MEN1 (0.51) CYP1A2CYP3A4MEN1ABCC9CYP2D6
SCHEMBL1610107 0.68 MEN1 (0.51) CYP1A2CYP3A4MEN1ABCC9CYP2D6
SCHEMBL3536058 0.67 HDAC1 (0.56) MEN1KMT2AMAPK1SMN1; SMN2ALDH1A1
SCHEMBL2497201 0.67 ABCC9 (0.62) CYP1A2CYP3A4MEN1ABCC9CYP2D6
SCHEMBL6647586 0.67 ABCC9 (0.62) CYP1A2CYP3A4MEN1ABCC9CYP2D6
SCHEMBL3633060 0.66 ABCC9 (0.58) CYP1A2CYP3A4MEN1ABCC9CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262158-B1 Cleansing compositions comprising a liquid silicone and ester mixture JOHNSON & JOHNSON COMPANIES, INC. (US) 2007-08-28 US claimed
US-6762158-B2 SUITABLE FOR USE IN SKIN CARE APPLICATIONS, WHICH EFFECTIVELY DELIVER AND/OR DEPOSIT VARIOUS BENEFIT AGENTS INTO AND ONTO THE SKIN AND WHICH ARE RELATIVELY NON-IRRITATING JOHNSON & JOHNSON CONSUMER COMPANIES, INC. 2004-07-13 US claimed
EP-1216685-A2 Personal care compositions Johnson & Johnson Consumer Companies, Inc. (US) 2002-06-26 EP claimed
US-20020077256-A1 NOVEL DETERGENT COMPOSITIONS WITH ENHANCED DEPOSITING, CONDITIONING AND SOFTNESS CAPABILITIES JOHNSON & JOHNSON CONSUMER INC. 2002-06-20 US claimed
US-20020035046-A1 Personal care compositions JOHNSON & JOHNSON CONSUMER INC. 2002-03-21 US claimed
WO-2001001949-A9 CLEANSING COMPOSITIONS JOHNSON & JOHNSON CONSUMER (US) 2001-03-22 WO claimed
WO-2001001949-A1 CLEANSING COMPOSITIONS JOHNSON AND JOHNSON CONSUMER COMPANIES, INC. (US) 2001-01-11 WO claimed
US-20250248911-A1 Composition Containing a Cellulose Derived Capsule With a Sunscreen COLABS INT'L CORP. (US) 2025-08-07 US disclosed
US-20240099948-A1 Compositions Comprising Silicon Dioxide-Based Particles Including One or More Agents COLABS INT'L CORP. (US) 2024-03-28 US disclosed
US-11839674-B2 Compositions comprising silicon dioxide-based particles including one or more agents CoLabs International Corporation (US) 2023-12-12 US disclosed
US-20230338252-A1 Composition Containing a Cellulose Derived Capsule With a Sunscreen COLABS INT'L CORP. (US) 2023-10-26 US disclosed
US-11724134-B2 Compositions containing a cellulose derived capsule with a sunscreen active agent CoLabs International Corporation (US) 2023-08-15 US disclosed
US-11707421-B2 Compositions containing a flexible derived capsule with an active agent COLABS INT'L CORP. (US) 2023-07-25 US disclosed
US-20020077256-A1 NOVEL DETERGENT COMPOSITIONS WITH ENHANCED DEPOSITING, CONDITIONING AND SOFTNESS CAPABILITIES JOHNSON & JOHNSON CONSUMER INC. 2002-06-20 US disclosed
US-20020035046-A1 Personal care compositions JOHNSON & JOHNSON CONSUMER INC. 2002-03-21 US disclosed
US-6274587-B1 SEXUAL, EATING, CARDIOVASCULAR, BRAIN, NERVOUS SYSTEM, GASTROINTESTINAL AND UROGENITAL DISORDERS ABBOTT LABORATORIES 2001-08-14 US disclosed
WO-2001001949-A9 CLEANSING COMPOSITIONS JOHNSON & JOHNSON CONSUMER (US) 2001-03-22 WO disclosed
EP-1080714-A2 Detergent compositions with enhanced depositing, conditioning and softness capabilities Johnson & Johnson Consumer Companies, Inc. (US) 2001-03-07 EP disclosed
WO-2001001949-A1 CLEANSING COMPOSITIONS JOHNSON AND JOHNSON CONSUMER COMPANIES, INC. (US) 2001-01-11 WO disclosed
EP-1060732-A2 Novel topical formulations comprising vesicle delivery systems JOHNSON & JOHNSON CONSUMER PRODUCTS, INC. (US) 2000-12-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11707421-B2 Compositions containing a flexible derived capsule with an active agent CUTA, LIPE, LIPA CYP1A2 2522/4885CYP3A4 3480/4885MEN1 299/4885
US-11724134-B2 Compositions containing a cellulose derived capsule with a sunscreen active agent CUTA, ACMSD, TYR CYP1A2 1054/4885CYP3A4 2323/4885MEN1 139/4885
US-20230338252-A1 Composition Containing a Cellulose Derived Capsule With a Sunscreen MSH6, TYR, CUTA CYP1A2 400/4885CYP3A4 1425/4885MEN1 59/4885
US-20020035046-A1 Personal care compositions CUTA, DSG1, KRT18 CYP1A2 4130/4885CYP3A4 4523/4885MEN1 2871/4885
US-20020077256-A1 NOVEL DETERGENT COMPOSITIONS WITH ENHANCED DEPOSITING, CONDITIONING AND SOFTNESS CAPABILITIES DSTN, CTTN, SMURF1 CYP1A2 4581/4885CYP3A4 4771/4885MEN1 1258/4885
US-20240099948-A1 Compositions Comprising Silicon Dioxide-Based Particles Including One or More Agents MSN, LIPE, CUTA CYP1A2 2852/4885CYP3A4 3904/4885MEN1 84/4885
US-11839674-B2 Compositions comprising silicon dioxide-based particles including one or more agents MSN, LIPE, CUTA CYP1A2 2906/4885CYP3A4 3902/4885MEN1 81/4885
US-20250248911-A1 Composition Containing a Cellulose Derived Capsule With a Sunscreen MSH6, TYR, CUTA CYP1A2 400/4885CYP3A4 1425/4885MEN1 59/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.